Work

Supplementary Figure 5 from FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure 5 (A) IL-15 amounts in serum of Balb/c mice treated with RT, anti-CD25, anti-asialoGM1 to deplete NK cells, and FLT3L; **** p{less than or equal to}0.0001; n=6. (B) Flow cytometric analysis of DCs MOC2 tumors after treatment with radiation therapy and anti-CD25; n=5. (C) growth curves of MOC2 tumors in individual mice treated with radiation therapy, anti-CD25, and anti-CD137.
Language: English
Subfield: Immunology
Open Access status: gold
OpenAlex ID: W4361827733
Cites:
Cited by:
Related to: 10